The news of Advanced Health Intelligence obtaining overseas R&D reimbursement under the Australian Research and Development Tax Incentive Scheme is directly related to the company and is a positive development. This could lead to increased revenues for the company, which is likely why the stock price has increased. The importance is high as this could significantly impact the company's financials. The confidence in this analysis is high as the correlation between such incentives and stock price increases is well established.